Evidence
Retatrutide results timeline explorer
Trial endpoints are not personal predictions. They are structured research timepoints under medical monitoring.
Explore trial endpoint timing
Early clinical endpoint
Lilly reported phase 2 weight outcomes at 24 weeks. This is a trial endpoint, not a promise of personal results.
Do not use trial endpoints to self-dose or evaluate a product claiming to be retatrutide.
Medical disclaimer
This tool is for informational purposes only and does not constitute medical advice. I am not a medical professional. Always consult a qualified healthcare provider before starting, stopping, or changing any weight loss treatment. Retatrutide is investigational and is not FDA approved.